Drugs Made In America Acquisition Corp. (DMAA)
Q2-CY2026Q1-CY2026Q4-CY2025Q3-CY2025Q2-CY2025Q1-CY2025Q4-CY2024Q3-CY2024Q2-CY2024Q1-CY2024Q4-CY2023Q3-CY2023Q2-CY2023Q1-CY2023Q4-CY2022Q3-CY2022Q2-CY2022Q1-CY2022Q4-CY2021Q3-CY2021Q2-CY2021Q1-CY2021Q4-CY2020Q3-CY2020Q2-CY2020Q1-CY2020Q4-CY2019Q3-CY2019Q2-CY2019Q1-CY2019Q4-CY2018Q3-CY2018Q2-CY2018Q1-CY2018Q4-CY2017Q3-CY2017Q2-CY2017Q1-CY2017Q4-CY2016Q3-CY2016Q2-CY2016Q1-CY2016Q4-CY2015Q3-CY2015Q2-CY2015Q1-CY2015Q4-CY2014Q3-CY2014Q2-CY2014
Balance Sheet Date2025-Dec-312025-Sep-302025-Jun-302025-Mar-312024-Dec-31
Fiscal PeriodQ4-FY2025Q3-FY2025Q2-FY2025Q1-FY2025Q4-FY2024
Close Price of Common Stock10.51$10.50$10.31$10.27$10.18$10.01$
Market Cap of Common Stock352,265,173$351,930,002$345,394,159$344,221,059$341,204,516$
QoQ%.10%1.89%.34%.88%
YoY%3.24%
Close Price of Warrant
Close Price of Unit10.58$10.51$10.48$10.40$10.30$10.15$
Close Price of Right0.09$0.06$0.16$0.22$0.15$0.13$
Common Shares Outstanding33,717,14310,717,14310,517,14310,517,14310,517,1439,857,1439,857,1439,857,143
QoQ%1.90%.00%.00%6.70%.00%.00%
YoY%220.59%8.73%6.70%6.70%